Results · Apr-Jun 2026
Mukka Proteins Q1 FY27 results
Sales grew 187% to ₹490 crore from ₹171 crore in Apr-Jun 2025.
Operating profit grew 230% to ₹48 crore, an operating margin of 9.8% (up 1.3 points from a year ago).
Net profit grew 1073% to ₹18.6 crore from ₹1.6 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +29%, net profit −13%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 489.7 | 170.8 | +187% |
| Operating profit (EBITDA) | 48.0 | 14.6 | +230% |
| Operating margin | 9.8% | 8.5% | +1.3 pts |
| Net profit | 18.6 | 1.6 | +1073% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.